Today, the ELISA (Enabling Linux in Safety Applications) Project welcomes Hamburg University Technology - Institute of Aircraft Systems Engineering and Lynx Software Technologies to its ecosystem....

ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk BCG-failure non-muscle invasive bladder...

Median duration of response reaches 7.4 months with combination treatment in patients with aggressive form of disease New results show potential of RYBREVANT® beyond lung cancer BARCELONA, Sept....

SmallRig recently showcased three innovative products at the IBC Show 2024 in the Netherlands. These cutting-edge releases are designed to revolutionize the way creators approach lighting and...

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE,...